GSE178340 7 V 9 CARFILZOMIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE178340 7 V 9 CARFILZOMIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE178340 7 V 9 CARFILZOMIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE178340 7 V 9 CARFILZOMIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE178340 7 V 9 CARFILZOMIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

RAD52 motif containing 1

Gene

CENPS-CORT readthrough

Gene

DNA polymerase delta 3, accessory subunit

Gene

B cell receptor associated protein 29

Gene

SFT2 domain containing 2

Gene

F-box DNA helicase 1

Gene

ankyrin repeat and LEM domain containing 2

Gene

proline rich nuclear receptor coactivator 2

Gene

HMG-box containing 4

Gene

SREBF pathway regulator in golgi 1

  • Gene

    RAD52 motif containing 1


  • Gene

    CENPS-CORT readthrough


  • Gene

    DNA polymerase delta 3, accessory subunit


  • Gene

    B cell receptor associated protein 29


  • Gene

    SFT2 domain containing 2


  • Gene

    F-box DNA helicase 1


  • Gene

    ankyrin repeat and LEM domain containing 2


  • Gene

    proline rich nuclear receptor coactivator 2


  • Gene

    HMG-box containing 4


  • Gene

    SREBF pathway regulator in golgi 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.